Sabra Healthcare REIT Inc - Cost of Goods Sold Including Depreciation and Amortization

Sabra Healthcare REIT Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.

The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 250.53 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Sabra Healthcare REIT Inc's third quarter result of 69.65 Million USD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 14.00 percent compared to it's second quarter result.

Also, Sabra Healthcare REIT Inc's third quarter result of 69.65 Million USD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 19.06 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sabra Healthcare REIT Inc's third quarter result of 250.53 Million USD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 4.66 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 15.38 percent compared to the value the year prior.
The 1 year change in percent is 15.38.
The 3 year change in percent is 61.91.
The 5 year change in percent is 97.55.
The 10 year change in percent is 1,120.65.

The Serie's long term average value is 90.99 Million United States Dollars. It's latest available value, on 09/30/2025, is 175.33 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2016, to it's latest available value, on 09/30/2025, is +4,547.13%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.